Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

This publication has 13 references indexed in Scilit:

• Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
  Fertility and Sterility, 2001
• Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study
  Fertility and Sterility, 2001
• Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 2000
• Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome
  Published by Elsevier ,2000
• Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome
  New England Journal of Medicine, 1998
• Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
  Fertility and Sterility, 1998
• Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
  Obstetrics & Gynecology, 1997
• Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
  Journal of Clinical Investigation, 1995
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
  Metabolism, 1994
• Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome
  Diabetes, 1992